Michael J. Becich, MD, PhD

Weng C, Becich MJ, Fridsma D.  Collective Domain Modeling across Clinical Trials Standards:  Needs, Challenges, and Design Implications.  Proceeding of The International Conference on Information Technology and Communications in Health (ITCH), February 2007, Victoria, Canada.

Niland JC, Townsend RM, Annechiarico R, Johnson K, Beck JR, Manion FJ, Hutchinson F, Robbins /RJ, Chute CG, Vogel LH, Saltz JH, Watson MA, Casavant TL, Soong Sj, Bondy J, Fenstermacher DA, Becich MJ, Casagrande JT, Tuck DP.  The Cancer Biomedical Informatics Grid (caBIG): infrastructure and applications for a worldwide research community.   Medinfo. 2007;12(Pt 1):330-4. PMID: 17911733

Chandran UR, Dhir R, Ma C, Michalopoulos G, Becich M, Gilbertson J. (2005). Differences in gene expression in prostate cancer, normal appearing prostate tissue adjacent to cancer and prostate tissue from cancer free organ donors. BMC Cancer, 5, 45. http://doi.org/10.1186/1471-2407-5-45 PMID: 15892885 PMCID: PMC1173092

Varambally S, Yu J, Laxman B, Rhodes DR, Mehra R, Tomlins SA, Shah RB, Chandran U, Monzon FA, Becich MJ, Wei JT, Pienta KJ, Ghosh D, Rubin MA, Chinnaiyan AM. Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer cell. 2005 Nov;8(5):393-406. PMID: 16286247

Chandran U, Monzon FA, Becich MJ, Gilbertson J. A new pathology biomarker laboratory. Proc. Medinfo. (CD). 2004;(0):1546.

^